Understanding the Connection: Oolong Tea and Diabetes Management

Diabetes mellitus ranks among the most pressing metabolic disorders worldwide, affecting an estimated 537 million adults. The hallmark of the disease is chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. While pharmacological interventions remain central to treatment, mounting evidence points to dietary adjuncts that may support metabolic control. Among these, oolong tea—a traditional Chinese tea with a distinctive semi-oxidation process—has drawn scientific interest for its potential to influence pancreatic beta cell function. This article examines the current evidence linking oolong tea consumption to improved beta cell health, exploring the mechanisms, clinical findings, and practical applications for diabetes patients.

The Global Burden of Diabetes and the Need for Adjunctive Therapies

The International Diabetes Federation reports that diabetes prevalence continues to rise, with projections reaching 643 million by 2030. The economic burden is substantial, with global health expenditures exceeding $966 billion annually. While insulin and oral hypoglycemic agents remain cornerstone treatments, adherence challenges, side effects, and progressive disease nature have spurred interest in complementary approaches. Dietary polyphenols, particularly those found in tea, have emerged as promising candidates due to their accessibility, safety profile, and multi-targeted mechanisms of action.

The Role of Pancreatic Beta Cells in Diabetes

Pancreatic beta cells reside in the islets of Langerhans and are the sole source of insulin, the hormone that facilitates glucose uptake into cells. The adult human pancreas contains approximately one million islets, each housing 2,000–3,000 beta cells. In a healthy individual, beta cells respond to rising blood glucose by secreting insulin in a precise, biphasic manner. The first phase occurs within minutes of glucose exposure, releasing preformed insulin granules, while the second phase involves sustained secretion of newly synthesized insulin. In type 2 diabetes, this system breaks down: beta cells become dysfunctional, their mass declines, and insulin secretion falters. This progressive loss of functional beta cell mass is a key driver of disease progression.

Type 1 vs Type 2 Diabetes and Beta Cell Dysfunction

In type 1 diabetes, an autoimmune attack destroys beta cells, leading to absolute insulin deficiency. The process typically begins years before clinical diagnosis, with autoantibodies targeting insulin, glutamic acid decarboxylase, and other beta cell antigens. For type 2 diabetes, the pathophysiology is more complex. Insulin resistance initially increases demand on beta cells, which attempt to compensate with greater insulin output. This compensatory phase can last years, but eventually, the beta cells begin to fail. Chronic overwork induces endoplasmic reticulum stress, oxidative damage, mitochondrial dysfunction, and eventually beta cell apoptosis. Postmortem studies reveal that people with type 2 diabetes have lost approximately 40–60% of their beta cell mass by the time of diagnosis. Preserving beta cell mass and function therefore represents a critical therapeutic goal in both diabetes types, and interventions that can slow or reverse this decline are highly sought after.

The Unique Position of Oolong Tea Among Tea Varieties

All traditional teas come from the same plant species, Camellia sinensis, but differ in processing. Oolong tea undergoes partial oxidation—typically 10–70%, placing it between green tea (unoxidized) and black tea (fully oxidized). This controlled oxidation yields a distinctive polyphenol profile that sets oolong apart. The key bioactive compounds in oolong tea include: monomeric catechins such as epigallocatechin gallate (EGCG), epicatechin gallate (ECG), and epigallocatechin (EGC); dimeric theaflavins formed during oxidation; polymeric thearubigins; and unique compounds like oolongtheanin, which is formed specifically during oolong processing. Additionally, oolong tea contains L-theanine, an amino acid with relaxing properties, and moderate levels of caffeine. This complex phytochemistry provides a broad spectrum of potential biological activities, many of which are relevant to metabolic health and beta cell function.

Scientific Evidence: Oolong Tea and Beta Cell Function

Research exploring oolong tea's impact on pancreatic beta cells has progressed from cellular models to human interventions. While large-scale randomized trials remain sparse, the cumulative evidence points to a protective and even restorative role for beta cells. Understanding this evidence base requires careful examination of studies across different experimental systems.

Mechanistic Insights from Cellular Models

In vitro research provides the foundation for understanding how oolong tea components interact with beta cells at the molecular level. Studies using INS-1 rat insulinoma cells, a well-established beta cell model, have demonstrated that oolong tea extract protects against cytokine-induced cell death. Inflammatory cytokines such as interleukin-1 beta (IL-1β), tumor necrosis factor alpha (TNF-α), and interferon gamma (IFN-γ) are elevated in the islet microenvironment of diabetic patients and contribute to beta cell destruction. Oolong tea extract suppresses activation of the nuclear factor kappa B (NF-κB) pathway, a master regulator of inflammatory gene expression. By inhibiting NF-κB nuclear translocation, oolong tea components reduce the expression of pro-inflammatory genes and inducible nitric oxide synthase, thereby decreasing nitric oxide-mediated damage to beta cells.

Additionally, oolong tea polyphenols upregulate expression of pancreatic duodenal homeobox-1 (PDX-1), a transcription factor critical for beta cell maintenance, proliferation, and insulin gene transcription. PDX-1 is often downregulated in diabetic states, contributing to beta cell dysfunction. The ability of oolong tea compounds to restore PDX-1 expression suggests a mechanism for preserving beta cell identity and function. Furthermore, oolong tea extracts have been shown to activate the Nrf2/ARE antioxidant response pathway, increasing the expression of phase II detoxification enzymes such as heme oxygenase-1 and NAD(P)H quinone oxidoreductase 1. This enhances the beta cell's intrinsic capacity to neutralize oxidative stress.

Animal Studies: In Vivo Evidence of Beta Cell Protection

Animal models offer the opportunity to study oolong tea effects in a whole-organism context, accounting for absorption, metabolism, and tissue distribution. In a landmark study using streptozotocin-induced diabetic rats, administration of oolong tea polyphenols for four weeks significantly increased serum insulin levels and restored beta cell mass, as quantified by immunohistochemical staining for insulin. Histological examination revealed reduced beta cell apoptosis, as detected by TUNEL assay, and improved islet architecture with more organized cell clusters. These results were attributed to enhanced activity of antioxidant enzymes such as superoxide dismutase and catalase, which quenched reactive oxygen species that otherwise damage beta cells.

In another study using db/db mice, a genetic model of type 2 diabetes, dietary supplementation with oolong tea extract for eight weeks reduced fasting blood glucose by 23% and improved glucose tolerance during an oral glucose tolerance test. Pancreatic tissue analysis showed increased beta cell proliferation, as indicated by Ki67 staining, and reduced beta cell apoptosis. Importantly, the study also found that oolong tea treatment preserved the expression of glucose transporter 2 (GLUT2), the glucose sensor on beta cells that is often downregulated in diabetes. This preservation of glucose sensing capacity could explain the improved insulin secretion observed in treated animals.

A particularly interesting study examined the effects of oolong tea on pancreatic islets in aged rats, a model of age-related beta cell decline. Aged rats fed oolong tea for 12 weeks showed increased islet size and number, improved insulin content per islet, and better glucose-stimulated insulin secretion compared to controls. These findings suggest that oolong tea may have benefits not only in diabetic models but also in preventing age-related decline in beta cell function.

Human Clinical Trials: Translating Preclinical Findings

Human studies, though fewer, have yielded encouraging results that align with preclinical work. A randomized crossover trial published in Diabetes Care investigated the effects of oolong tea in patients with type 2 diabetes. Participants consumed oolong tea (1500 mL daily for 30 days) and experienced significantly lower fasting plasma glucose and hemoglobin A1c levels compared to a water control group. Importantly, markers of insulin secretion, such as C-peptide levels and the homeostasis model assessment of beta cell function (HOMA-B), improved, suggestive of enhanced beta cell function. The effect size was clinically meaningful: fasting glucose decreased by an average of 30 mg/dL, and HbA1c dropped by 0.6 percentage points.

Another study examined the acute effects of oolong tea on postprandial glucose and insulin dynamics. After consuming a standardized mixed meal, participants who drank oolong tea (1.5 grams in 300 mL water) exhibited lower glycemic excursions, with peak glucose reduced by 17% compared to water. The early-phase insulin response was significantly higher in the oolong tea group, indicating preserved beta cell responsiveness to glucose stimulation. This acute effect suggests that oolong tea components can rapidly modulate insulin secretion, likely through direct effects on beta cell signaling.

Longer-term studies have also been conducted. A 16-week randomized controlled trial in Japanese adults with impaired glucose tolerance found that three cups of oolong tea daily improved glucose tolerance and reduced progression to diabetes compared to a placebo beverage. Beta cell function, assessed by the insulinogenic index from an oral glucose tolerance test, improved in the oolong tea group but declined in the placebo group. The number needed to treat to prevent one case of diabetes was approximately 12 over the study period, a clinically relevant effect comparable to some lifestyle interventions.

However, it is important to note limitations in the human evidence. Most studies have been small, with sample sizes ranging from 20 to 100 participants. Duration has been relatively short, typically 4–16 weeks. Standardization of oolong tea preparations varies between studies, with differences in oxidation level, brewing method, and polyphenol content. Compliance monitoring has been inconsistent. Larger, longer-term trials with standardized preparations are needed to confirm these findings and establish definitive clinical recommendations.

Mechanisms of Action: How Oolong Tea Supports Beta Cell Health

The beneficial effects of oolong tea on beta cells are multifaceted, operating through antioxidant, anti-inflammatory, insulin-sensitizing, and directly insulinotropic pathways. Understanding these mechanisms provides a framework for predicting clinical effects and identifying potential synergies with other therapeutic approaches.

Polyphenol-Rich Antioxidant Effects

Beta cells are uniquely vulnerable to oxidative stress for several reasons. They express low levels of antioxidant enzymes such as glutathione peroxidase, catalase, and superoxide dismutase compared to other tissues. They also have high metabolic activity, generating reactive oxygen species during glucose metabolism. Chronic hyperglycemia further increases oxidative stress through glucose autoxidation, formation of advanced glycation end products, and activation of the polyol pathway. This creates a vicious cycle: oxidative stress impairs beta cell function, leading to worse glycemic control, which in turn generates more oxidative stress.

The high polyphenol content in oolong tea, especially catechins and theaflavins, directly scavenges free radicals and chelates pro-oxidant metal ions such as iron and copper. Oolong tea extracts have been shown to reduce reactive oxygen species levels in beta cells by up to 50% in vitro. This antioxidant protection reduces lipid peroxidation of beta cell membranes, preserves mitochondrial membrane potential, and maintains ATP production—critical for glucose-stimulated insulin secretion. Mitochondrial function is particularly important because the ATP/ADP ratio generated by mitochondrial metabolism is the primary signal for insulin granule exocytosis.

Notably, oolong tea's antioxidant capacity as measured by ORAC (Oxygen Radical Absorbance Capacity) falls between that of green and black teas. However, the partial oxidation process yields compounds like oolongtheanin that may be more bioavailable in the gastrointestinal tract, allowing them to reach the pancreas in active form. Some studies suggest that oolong tea polyphenols have higher resistance to gastric acid degradation compared to green tea catechins, potentially increasing delivery to target tissues.

Anti-Inflammatory Pathways

Chronic low-grade inflammation is a hallmark of type 2 diabetes and contributes to beta cell dysfunction through multiple mechanisms. Inflammatory cytokines such as TNF-α, IL-1β, and IL-6 impair insulin secretion, induce beta cell dedifferentiation, and promote apoptosis. Macrophage infiltration into islets is increased in diabetic patients, and these immune cells secrete cytokines that damage beta cells. Additionally, islet amyloid polypeptide aggregates, which accumulate in type 2 diabetic islets, activate the NLRP3 inflammasome, leading to IL-1β production and further inflammation.

Oolong tea extracts have been shown to suppress cytokine production in macrophages by inhibiting the TLR4/MyD88/NF-κB signaling pathway. They also reduce activation of the NLRP3 inflammasome, lowering IL-1β secretion from islet-resident macrophages. In beta cells themselves, oolong tea polyphenols reduce activation of the JNK and p38 MAPK pathways, which are stress-responsive kinases that impair insulin gene transcription and promote apoptosis. By dampening these inflammatory signals at multiple levels, oolong tea helps maintain a healthier microenvironment for beta cells, reducing inflammatory stress and preserving function.

The anti-inflammatory effects of oolong tea appear to be mediated by both monomeric catechins and dimeric theaflavins. Theaflavin-3,3'-digallate, a compound found in oolong and black teas, is a particularly potent anti-inflammatory agent, inhibiting NF-κB activation at nanomolar concentrations. This compound is largely absent in green tea, suggesting that the partial oxidation process generates unique anti-inflammatory molecules not available in other tea types.

Modulation of Insulin Signaling and Glucose Metabolism

Beyond direct beta cell protection, oolong tea improves peripheral insulin sensitivity, which reduces the secretory demand placed on beta cells and allows them to function more efficiently. Oolong tea polyphenols activate AMP-activated protein kinase (AMPK) in skeletal muscle and liver, enhancing glucose uptake and suppressing hepatic gluconeogenesis. AMPK activation in skeletal muscle promotes GLUT4 translocation to the cell surface, increasing glucose clearance from the bloodstream. In the liver, AMPK phosphorylation inhibits gluconeogenic enzymes such as phosphoenolpyruvate carboxykinase and glucose-6-phosphatase, reducing hepatic glucose output.

Oolong tea also inhibits intestinal alpha-glucosidase enzymes, which break down complex carbohydrates into absorbable monosaccharides. This effect reduces the rate of glucose absorption after meals, blunting postprandial glucose spikes and reducing the acute demand on beta cells for insulin secretion. In vitro studies show that oolong tea extracts inhibit alpha-glucosidase more potently than green tea extracts, possibly due to the higher content of polymeric polyphenols formed during oxidation.

Furthermore, oolong tea components may directly stimulate insulin secretion from beta cells. Certain polyphenols, particularly EGCG and theaflavins, have been shown to increase intracellular calcium levels in beta cells, promoting insulin granule exocytosis. This insulinotropic effect is glucose-dependent, meaning that oolong tea components enhance insulin secretion only when glucose levels are elevated, reducing the risk of hypoglycemia. This glucose-dependent mechanism is similar to the action of DPP-4 inhibitors and GLP-1 receptor agonists, but occurs through distinct signaling pathways involving L-type calcium channels and protein kinase A.

Epigenetic Effects and Gene Expression Regulation

Emerging evidence suggests that oolong tea polyphenols may influence beta cell function through epigenetic mechanisms. EGCG has been shown to inhibit DNA methyltransferases and histone deacetylases, enzymes that regulate gene expression through chromatin modification. In beta cells, these epigenetic changes could potentially reactivate silenced genes involved in insulin production and cell survival. For example, oolong tea treatment has been associated with increased histone acetylation at the insulin gene promoter, enhancing transcription. These epigenetic effects may explain how relatively short-term tea consumption can produce sustained improvements in beta cell function.

Practical Applications for Diabetes Patients

Integrating oolong tea into a diabetes management plan requires consideration of dosage, preparation, timing, and potential interactions with medications. While oolong tea is generally safe, informed use maximizes benefits and minimizes risks.

Most clinical studies have used 3–6 cups (750–1500 mL) of freshly brewed oolong tea daily, providing 600–1200 mg of total polyphenols. This intake level has been well tolerated in studies lasting up to 16 weeks, with no serious adverse effects reported. To maximize polyphenol extraction, use the following brewing parameters:

  • Water temperature: 85–90°C (185–194°F)—water that is too hot can degrade heat-sensitive polyphenols, while water that is too cool will not extract them efficiently.
  • Leaf-to-water ratio: 2–3 grams of loose leaf tea per 200 mL water (approximately one rounded teaspoon per cup).
  • Steep time: 3–5 minutes for the first infusion; oolong leaves can typically be re-steeped 2–3 times with slightly increasing steep times.
  • Avoid additives: Do not add sugar, honey, milk, or cream. Dairy proteins can bind to tea polyphenols, forming complexes that reduce intestinal absorption. Sugar adds empty calories and negates the glycemic benefits.

Timing matters for metabolic benefit. Consuming oolong tea with or shortly before meals appears to maximize the postprandial glucose-lowering effect. Studies showing improved insulin secretion and reduced glycemic excursions typically administered tea 15–30 minutes before a meal. Spreading consumption throughout the day may provide more consistent coverage, but avoid drinking tea too close to bedtime if caffeine sensitivity is an issue, as it may disrupt sleep, which is itself important for glycemic control.

Consistency is key. Intermittent consumption may not yield sustained metabolic improvements. Patients should view oolong tea as a complementary lifestyle measure to be integrated into their daily routine, not a replacement for prescribed medications or dietary guidelines. Studies suggest that benefits begin to appear after 2–4 weeks of regular consumption and may require ongoing intake to be maintained.

Choosing the Right Oolong Tea

Not all oolong teas are created equal. The degree of oxidation significantly affects polyphenol content and composition. For metabolic benefits, oolong teas with moderate oxidation (30–50%) appear to offer the best balance of catechins and theaflavins. Traditional high-quality oolongs such as Tieguanyin (Iron Goddess) from Fujian province, Dong Ding from Taiwan, and Wuyi Rock teas (Yancha) are good choices. For those concerned about cost, more affordable everyday oolongs still provide significant polyphenol content. Look for teas sold in loose leaf form rather than tea bags, as whole leaves typically retain more bioactive compounds.

Storage matters. Polyphenols are sensitive to light, heat, and oxygen. Store oolong tea in an airtight container in a cool, dark place. Avoid storing near the stove or in direct sunlight. Properly stored, oolong tea maintains its polyphenol content for 6–12 months. For maximum benefit, purchase tea from reputable sources that provide harvest dates and oxidation levels.

Potential Interactions and Precautions

Mayo Clinic notes that while tea is generally safe, there are several considerations for diabetes patients. First, the caffeine content (approximately 30–50 mg per cup, about half that of coffee) may interact with certain medications or exacerbate anxiety, insomnia, or arrhythmias in sensitive individuals. For those with caffeine sensitivity, a decaffeinated oolong option may be considered, though some studies suggest that the decaffeination process can reduce polyphenol content by 10–30%. Alternatively, short steep times or discarding the first 30-second infusion can reduce caffeine content while retaining most polyphenols.

Second, individuals taking anticoagulant medications such as warfarin should be aware that tea contains vitamin K. However, oolong tea contains significantly less vitamin K than green leafy vegetables—approximately 5 mcg per cup compared to 100+ mcg in a serving of kale. For most patients on warfarin, moderate tea consumption does not require dose adjustment, but it is prudent to maintain consistent intake if monitoring INR.

Third, oolong tea polyphenols can inhibit non-heme iron absorption by forming insoluble complexes with iron ions in the gastrointestinal tract. This effect is dose-dependent and most pronounced when tea is consumed with meals. Patients at risk for iron deficiency—including those with chronic blood loss, pregnant women, and vegetarians—should consume oolong tea between meals rather than with food. Adding a source of vitamin C, such as lemon juice, can partially counteract this effect by keeping iron in a more absorbable reduced form.

Medication timing. Polyphenols can interact with certain medications. Studies suggest that EGCG and theaflavins may inhibit organic anion-transporting polypeptides (OATPs), which are involved in the absorption of some drugs, including certain statins and beta-blockers. To minimize potential interactions, drink tea at least two hours apart from medication ingestion. This is a standard precaution for dietary polyphenol intake and is recommended by the National Institutes of Health Office of Dietary Supplements.

As always, patients should consult their healthcare provider before making significant dietary changes, especially if managing diabetes with insulin or sulfonylureas where adjustments to medication doses may be needed. While oolong tea itself rarely causes hypoglycemia, the combination of tea consumption with other hypoglycemic interventions could theoretically increase risk.

Comparative Analysis: Oolong vs. Other Teas and Dietary Interventions

Understanding how oolong tea compares with other tea types and dietary interventions helps contextualize its potential role in diabetes management.

Oolong Tea vs. Green Tea for Beta Cell Health

Green tea has received extensive research attention for its anti-diabetic properties, largely attributed to its high EGCG content, which can constitute up to 30% of the dry leaf weight. EGCG has demonstrated potent antioxidant and anti-inflammatory effects in beta cell models, and large epidemiological studies in Japan and China have linked daily green tea consumption to reduced diabetes risk. However, oolong tea offers a distinct polyphenol profile due to partial oxidation. Theaflavins and thearubigins, present in oolong but not in green tea, have demonstrated unique anti-inflammatory and anti-apoptotic effects in beta cell models. Some head-to-head studies suggest that oolong tea may be more effective than green tea at reducing postprandial glucose, possibly because its larger polyphenol dimers are more resistant to gastrointestinal degradation and thus reach the pancreas in active form. A Korean study comparing the two directly found that oolong tea reduced postprandial glucose by 28% compared to 18% for green tea, using equal polyphenol doses.

Oolong Tea vs. Black Tea

Black tea, being fully oxidized, contains higher levels of theaflavins and thearubigins but lower levels of catechins compared to oolong. Studies of black tea have shown benefits for glucose metabolism, including improved insulin sensitivity and reduced postprandial glucose, but effects appear less pronounced than those observed with oolong. The intermediate oxidation level of oolong may provide an optimal balance of monomeric and dimeric polyphenols that neither green nor black tea achieves. Theaflavins from black tea have shown strong anti-inflammatory activity, but the absence of significant catechin content means that some antioxidant pathways may be less activated. For patients, the choice may ultimately depend on taste preference and palatability, as the health benefits of any tea require regular consumption.

Oolong Tea vs. Other Dietary Interventions

Compared with other dietary interventions studied for beta cell protection, such as cinnamon, berberine, and curcumin, oolong tea has several advantages. It is widely available, affordable, and well-tolerated with a long history of human consumption. Side effects are minimal when consumed in typical amounts. The evidence base, while still developing, is supported by multiple independent laboratories and includes mechanistic studies, animal models, and human data. Oolong tea also avoids the bioavailability challenges that limit some plant compounds; for example, curcumin has notoriously poor oral bioavailability, whereas oolong tea polyphenols achieve measurable plasma concentrations after oral ingestion.

However, it is important to set realistic expectations. The effects of oolong tea on beta cell function and glycemic control are modest compared with pharmacological interventions. A typical HbA1c reduction of 0.5–0.7 percentage points and fasting glucose reduction of 20–30 mg/dL, while clinically meaningful, are smaller than what can be achieved with metformin or GLP-1 receptor agonists. Oolong tea should be viewed as a component of a comprehensive diabetes management strategy, not a standalone treatment.

Future Research Directions

While current evidence is promising, several gaps remain that require further investigation. Rigorous, long-term randomized controlled trials with standardized oolong tea preparations are needed to confirm beta cell protection in humans. These trials should include objective measures of beta cell function, such as hyperglycemic clamp studies or frequently sampled intravenous glucose tolerance tests, rather than relying solely on fasting measures or oral glucose tolerance. Duration of at least 6–12 months would allow assessment of whether benefits are sustained over time.

Mechanistic studies should explore whether specific polyphenols in oolong tea directly activate regenerative pathways in beta cells. Recent work has identified small molecules that can induce beta cell replication or transdifferentiation from other pancreatic cell types such as alpha cells and exocrine cells. Whether oolong tea components have such activity is unknown but worth investigating. Additionally, research into the gut microbiota may reveal how oolong tea polyphenols are metabolized by gut bacteria into active compounds that influence the gut-pancreas axis. The gut microbiota composition is altered in type 2 diabetes, and dietary polyphenols can reshape the microbial community in ways that improve metabolic health. Prebiotic effects of oolong tea polyphenols may be as important as their direct antioxidant effects.

The dose-response relationship and the optimal oxidation level for metabolic benefit also warrant investigation. Individual genetic variability in polyphenol metabolism, mediated by polymorphisms in phase II enzymes such as catechol-O-methyltransferase and sulfotransferases, may influence who benefits most from oolong tea consumption. As the precision nutrition field advances, personalized recommendations based on genetic profile and gut microbiome composition may become feasible.

Finally, interactions between oolong tea and common diabetes medications should be systematically studied. While the pharmacological safety profile of tea appears favorable, formal studies of drug-tea interactions are lacking for most medications. This is particularly important for patients taking newer incretin-based therapies, where additive effects on insulin secretion could theoretically occur.

Conclusion

The scientific exploration of oolong tea as an adjunct to diabetes management reveals a compelling narrative: its polyphenol-rich composition, combined with partial oxidation, yields compounds that protect pancreatic beta cells from oxidative stress and inflammation while improving insulin sensitivity. Preclinical studies demonstrate that oolong tea extracts reduce beta cell apoptosis, preserve insulin secretion capacity, and improve glycemic control in animal models. Human clinical trials, though limited in number and scale, corroborate these findings, showing improvements in fasting glucose, HbA1c, and markers of beta cell function with regular oolong tea consumption.

For patients seeking natural strategies to support glycemic control, unsweetened oolong tea represents a low-risk, evidence-informed addition to a comprehensive diabetes care plan. When consumed consistently as part of a healthy diet and lifestyle, it may help preserve beta cell function, reduce postprandial glucose excursions, and improve overall metabolic health. The recommended intake of 3–6 cups daily, brewed fresh without additives, provides a meaningful dose of polyphenols that can be easily incorporated into daily routines. As research deepens and expands, this ancient beverage may find a modern role in preserving the health of insulin-producing cells and improving outcomes for the millions living with diabetes worldwide.